by John A. Jenkins | Dec 10, 2025 | FDA, FOIA, News Media, Pharmaceuticals
FOIAengine: The Investigative Outlet Gets Active at the FDA Capitol Forum may be one of the more under-the-radar journalistic enterprises in Washington, but recently it was easily the most active when it came to filing FOIA requests with the Food and Drug...
by John A. Jenkins | Dec 3, 2025 | FOIA, Short-Selling, Stock Market
FOIAengine: “Cassandra Unchained” Plays to Fear and Greed Michael Burry, the reclusive contrarian who foresaw the 2007 subprime collapse and became the reluctant hero of The Big Short, has walked away from professional money management for the second — and perhaps...
by John A. Jenkins | Nov 12, 2025 | FOIA, SEC
FOIAengine: SEC’s$2.5 Billion Outsourcing Contract Explained The Securities and Exchange Commission, which signed a staffing contract potentially worth $2.5 billion with a Texas-based Alaska Native corporation, appears to have relied heavily on the outside contractor...
by John A. Jenkins | Nov 5, 2025 | Antitrust, Cryptocurrency, FOIA, FTC, Politics, SEC
FOIAengine: Tort Lawyers, Watchdogs Continue the Fight The October 21 presidential pardon that wiped away Changpeng Zhao’s criminal history may have erased the felony conviction of the Binance founder, but it hasn’t freed his empire – or quieted the controversy. ...
by John A. Jenkins | Oct 29, 2025 | DOD, DOJ, FOIA, Politics
FOIAengine: A Paper Trail of Forewarnings When the Justice Department unsealed its indictment of John R. Bolton two weeks ago, it wasn’t the first time his name had surfaced in government files. Long before prosecutors accused the former national security adviser and...
by Randy E. Miller | Oct 16, 2025 | FDA, FOIA
FOIAengine: FDA Weight Loss Drug FOIA Requests Grow Leading makers of GLP-1 (Glucagon-Like Peptide-1) weight loss drugs like Ozempic and Zepbound are facing off against domestic compounding pharmacies that import foreign ingredients and make cheaper, non-approved...
